GREM1 and acute lymphoblastic leukemia: This study provides new insights into overcoming drug resistance, relapse, and death by elucidating the novel mechanism by which GREM1 deficiency induces adipogenic differentiation of BM‐MSCs and promotes B‐ALL disease progression.